Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-Associated non-hodgkin B-Cell lymphoma risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 2, 2014, Pages 343-349

  Vendrame, Elena ^a,b   Hussain, Shehnaz K ^a,d   Breen, Elizabeth Crabb ^a,c   Magpantay, Larry I ^a,b   Widney, Daniel P ^a,b   Jacobson, Lisa P ^e   Variakojis, Daina ^h   Knowlton, Emilee R ⁱ   Bream, Jay H ^f   Ambinder, Richard F ^g   Detels, Roger ^a,d   Mart́nez Maza, Otoniel ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Departments of Obstetrics and Gynecology   (United States)

^c Psychiatry and Biobehavioral Sciences   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Health Services and Epidemiology   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 31; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; NEOPTERIN; SCD40L PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HIV ASSOCIATED NON HODGKIN B CELL LYMPHOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; INFECTION RISK; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BISEXUALITY; BLOOD; HOMOSEXUALITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MULTIVARIATE ANALYSIS; VIROLOGY;

ADULT; BIOMARKERS, TUMOR; BISEXUALITY; CASE-CONTROL STUDIES; CYTOKINES; HIV INFECTIONS; HOMOSEXUALITY; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; MALE; MULTIVARIATE ANALYSIS;

EID: 84893658970     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0714     Document Type: Article

References (47)

1. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, LevineAM, Lukes RJ, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-570.
2. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-Associated non-Hodgkin lymphoma. Lancet 1991;337:805-809.
3. Epeldegui M, Vendrame E, Martínez-Maza O. HIV-Associated immune dysfunction and viral infection -role in the pathogenesis of AIDSrelated lymphoma. Immunologic Research 2010;48:72-83.
4. Martínez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 1987;138:3720-3724.
5. Martínez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 2002;14:528-532.
6. Epeldegui M, Thapa DR, De La Cruz J, Kitchen SG, Zack JA, Martínez-Maza O. CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS ONE 2010;5:e11488.
7. Imbeault M, Ouellet M, Giguere K, Bertin J, Belanger D, Martin G, et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J Virol 2011;85:2189-2200.
8. Epeldegui M, Breen EC, Hung YP, Boscardin WJ, Detels R, Martínez-Maza O. Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis. AIDS 2007;21:2265-2270.
9. Guo Y, Siewe B, Epeldegui M, Detels R, Landay A, Martínez-Maza O. TLR2 activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS related non-Hodgkin lymphoma (NHL) diagnosis. J Acquir Immune Defic Syndr 2013;64:204-210.
10. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008;40:108-112.
11. Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S, et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 2009;36:631-641.
12. Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-Associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev 2011;20:1303-1314.
13. Vendrame E, Martínez-Maza O. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res 2011;10:113-119.
14. Rabkin CS, Engels EA, Landgren O, Schuurman R, Camargo MC, Ruth Pfeiffer, et al.Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Am J Hematol 2011;86:875-878.
15. Ouedraogo DE, Makinson A, Kuster N, Nagot N, Rubbo PA, Bollore K, et al. Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients. J Clin Immunol 2013;33:22-29.
16. Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, et al. Circulating serum free light chains as predictive markers of AIDSrelated lymphoma. J Clin Oncol 2010;28:773-779.
17. Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, et al.Serumlevels of thechemokineCXCL13,genetic variation inCXCL13 and its receptor CXCR5, and HIV-Associated non-Hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev 2013;22:295-307.
18. Breen EC, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Martínez-Maza O. The development of AIDS-Associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol 1999;92:293-299.
19. Pluda JM, Venzon DJ, Tosato G, Lietzau J, Wyvill K, Nelson DL, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993;11:1099-1107.
20. Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, et al. Serum biomarkers of immune activation and subsequent risk of non-Hodgkin B-cell lymphoma among HIV-Infected women. Cancer Epidemiol Biomarkers Prev 2013;22:2084-2093.
21. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martínez-Maza O. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 2007;44:934-942.
22. Detels R, Jacobson L, Margolick J, Martínez-Maza O,Munoz A, Phair J, et al. The multicenter AIDS Cohort Study, 1983 to . . .. Public Health 2012;126:196-198.
23. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Unconjugated pteridines and the activation of macrophages by interferon gamma. Cancer Chemother Pharmacol 1990;25: 308-309.
24. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29:307-341.
25. Epeldegui M, Widney DP, Martínez-Maza O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-Associated molecular lesions. Curr Opin Oncol 2006;18:444-448.
26. Widney DP, Gui D, Popoviciu LM, Said JW, Breen EC, Huang X, et al. Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-Associated non-Hodgkin's lymphoma. AIDS Res Treat 2010;2010:164586.
27. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-1444.
28. Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, et al. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis 2007;66: 23-27.
29. Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O'Brien SJ, et al. Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype. Clin Immunol 2003;109:119-129.
30. Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 2011;74: 1-13.
31. Romagnani S, Maggi E, Liotta F, Cosmi L, Annunziato F. Properties and origin of human Th17 cells. Mol Immunol 2009;47:3-7.
32. Sasson SC, Smith S, Seddiki N, Zaunders JJ, Bryant A, Koelsch KK, et al. IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. Cytokine 2010;50:58-68.
33. Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, et al. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. AIDS 2010;24:1025-1033.
34. Widney DP, Olafsen T, Wu AM, Kitchen CM, Said JW, Smith JB, et al. Levels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-Associated Burkitt lymphoma cell line, 2F7. PLoS One 2013;8:e72414.
35. Crotty S, Johnston RJ, Schoenberger SP. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 2010;11:114-120.
36. Takagi R, Higashi T, Hashimoto K, Nakano K, Mizuno Y, Okazaki Y, et al. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol 2008;181:186-189.
37. Herbelin A, Elhadad S, Ouaaz F, de Groote D, Descamps-Latscha B. Soluble CD23 potentiates interleukin-1-induced secretion of interleukin-6 and interleukin-1 receptor antagonist by human monocytes. Eur J Immunol 1994;24:1869-1873.
38. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19: 683-765.
39. Takeshita S, Breen EC, Ivashchenko M, Nishanian PG, Kishimoto T, Vredevoe DL, et al. Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell Immunol 1995;165:234-242.
40. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 1987;166:1098-1108.
41. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197: 111-119.
42. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991;12:A49-53.
43. Huysentruyt LC, McGrath MS. The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma. J Leukoc Biol 2010;87:627-632.
44. Salemi M, Lamers SL, Huysentruyt LC, Galligan D, Gray RR, Morris A, et al. Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS ONE 2009; 4:e8153.
45. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-1371.
46. Lederman MM. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis. Thromb Haemost 2010;104:911-914.
47. Marks MA, Rabkin CS, Engels EA, Busch E, Kopp W, Rager H, et al. Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS 2013;27:469-474.